Real Chemistry Executive and Leadership Team

Jeffrey O'Connell, the Chief Operating Officer & Chief Technology Officer at Real Chemistry, manages the intersection of operational efficiency and technological innovation. O'Connell architects the scalable AI infrastructure that powers the company's healthcare solutions. By overseeing the deployment of advanced data platforms, the Chief Operating Officer & Chief Technology Officer ensures seamless integration across all service lines. This leadership role involves streamlining internal processes to maximize productivity while maintaining high standards for technical performance. O'Connell drives the digital transformation agenda, enabling the firm to deliver sophisticated, idea-driven experiences to healthcare clients. Through the optimization of technical resources, the Chief Operating Officer & Chief Technology Officer supports the company's commitment to data-centric commercial success. Jeffrey O'Connell maintains a focus on operational excellence, ensuring that technological capabilities align with the evolving needs of the global healthcare market. Ultimately, O'Connell secures the firm's competitive advantage through robust technical architecture.

Sherry Pudloski, the Group President, Rc Resolve & Corporate Affairs at Real Chemistry, directs the firm's reputation management and strategic corporate communications. Pudloski architects comprehensive frameworks for navigating complex healthcare regulatory environments and stakeholder relations. By overseeing the Rc Resolve division, the Group President, Rc Resolve & Corporate Affairs ensures that clients receive expert guidance on crisis management and corporate positioning. This leadership role involves coordinating with executive teams to align corporate affairs with the company's broader commercial goals. Sherry Pudloski drives initiatives that enhance the firm's influence within the healthcare industry, focusing on transparency and strategic impact. Through the management of corporate reputation, the Group President, Rc Resolve & Corporate Affairs supports the long-term stability and growth of the organization. Pudloski maintains a focus on high-level advocacy, ensuring that the company's voice remains authoritative and consistent across all global markets.

Becky Vonsiatsky, the President, Earned Media at Real Chemistry, directs the strategy for securing high-impact media coverage and public relations outcomes. Vonsiatsky architects campaigns that amplify the visibility of healthcare innovations through strategic earned media channels. By overseeing the media relations team, the President, Earned Media ensures that client narratives reach target audiences with precision and authority. This leadership role involves cultivating relationships with key industry influencers and journalists to drive brand awareness. Becky Vonsiatsky maintains a focus on delivering measurable results that support the commercial success of healthcare companies. Through the integration of data-driven media strategies, the President, Earned Media enhances the firm's ability to shape public perception. Vonsiatsky drives the expansion of media capabilities, ensuring that the company remains at the forefront of industry trends. Ultimately, the President, Earned Media secures significant market presence for clients through expert storytelling and strategic media placement.

Brenna Terry, the President, Integrated Communications at Real Chemistry, directs the convergence of public relations, digital strategy, and creative content. Terry architects unified communication programs that deliver cohesive messaging across all customer touchpoints. By overseeing the integrated communications department, the President, Integrated Communications ensures that client campaigns remain aligned with the company's AI-powered, idea-driven philosophy. This leadership role involves managing cross-disciplinary teams to execute complex communication strategies that drive commercial outcomes. Brenna Terry maintains a focus on operational synergy, ensuring that every communication effort supports the broader business objectives of the firm. Through the implementation of innovative engagement tactics, the President, Integrated Communications enhances the impact of healthcare brands in a crowded marketplace. Terry drives the development of integrated solutions that address the specific needs of global healthcare clients. Ultimately, the President, Integrated Communications secures brand consistency and market relevance through strategic, multi-channel communication efforts.

Brandon Pletsch, the President, Scientific Visualization at Real Chemistry, directs the creation of complex medical imagery and data-driven visual storytelling. Pletsch architects the visual strategies that translate intricate scientific concepts into accessible, high-impact experiences for healthcare audiences. By overseeing the scientific visualization team, the President, Scientific Visualization ensures that visual assets support the commercial success of pharmaceutical and biotech clients. This leadership role involves integrating advanced design technology with deep scientific expertise to drive engagement. Brandon Pletsch maintains a focus on innovation, ensuring that the firm's visual output remains at the cutting edge of the industry. Through the development of sophisticated visualization tools, the President, Scientific Visualization enhances the clarity and effectiveness of client communications. Pletsch drives the expansion of visual capabilities, supporting the company's mission to put the customer at the center of healthcare experiences. Ultimately, the President, Scientific Visualization secures market differentiation through superior visual communication.

Robert Blink, the Group President & Managing Partner at Real Chemistry, directs the strategic growth and client relationship management for key business units. Blink architects the operational frameworks that enable the firm to deliver high-value services to major healthcare accounts. By overseeing the management of diverse client portfolios, the Group President & Managing Partner ensures that service delivery remains consistent with the company's commercial goals. This leadership role involves fostering long-term partnerships and driving revenue growth through strategic account expansion. Robert Blink maintains a focus on organizational health, ensuring that teams are equipped to meet the complex demands of the healthcare sector. Through the alignment of client needs with the firm's AI-powered capabilities, the Group President & Managing Partner supports the overall mission of the organization. Blink drives the execution of business strategies that enhance the firm's market position. Ultimately, the Group President & Managing Partner secures sustainable financial performance through expert leadership.

Christine Abbott, the President at Real Chemistry, directs the strategic operations and business development initiatives for the firm. Abbott architects the growth strategies that allow the company to scale its AI-powered healthcare solutions across global markets. By overseeing core business functions, the President ensures that all departments remain aligned with the overarching mission of driving commercial success for clients. This leadership role involves coordinating with the executive team to optimize resource allocation and operational efficiency. Christine Abbott maintains a focus on market expansion, identifying new opportunities to deliver value to healthcare organizations. Through the implementation of robust business processes, the President supports the firm's commitment to customer-centric innovation. Abbott drives the execution of high-level initiatives that strengthen the company's competitive standing. Ultimately, the President secures the long-term viability and success of the organization through disciplined leadership and strategic oversight of all primary business operations.

Marian James, the President, Analytics & Insights (Social Insights, Market Research, Measurement, Real World Data) at Real Chemistry, directs the firm's data-driven intelligence capabilities. James architects the analytical frameworks that transform social insights, market research, and real-world data into actionable commercial strategies. By overseeing the analytics division, the President, Analytics & Insights (Social Insights, Market Research, Measurement, Real World Data) ensures that clients receive precise, evidence-based guidance. This leadership role involves managing the integration of complex data sets to drive informed decision-making across the healthcare landscape. Marian James maintains a focus on methodological rigor, ensuring that all insights support the company's mission of commercial success. Through the application of advanced measurement techniques, the President, Analytics & Insights (Social Insights, Market Research, Measurement, Real World Data) enhances the firm's ability to predict market trends. James drives the development of innovative analytical tools that keep the company at the forefront of data-driven healthcare marketing.

Cali Howitt, the President, Medical Communications (US) at Real Chemistry, directs the strategy for medical education and scientific communication within the North American market. Howitt architects programs that effectively communicate clinical data to healthcare professionals and stakeholders. By overseeing the medical communications team, the President, Medical Communications (US) ensures that scientific narratives are accurate, compelling, and aligned with client commercial objectives. This leadership role involves managing the development of educational content that supports the adoption of new healthcare therapies. Cali Howitt maintains a focus on regulatory compliance and scientific integrity, ensuring that all communications meet the highest industry standards. Through the integration of AI-powered insights, the President, Medical Communications (US) enhances the reach and impact of medical information. Howitt drives the expansion of medical communication services, supporting the firm's mission to improve healthcare outcomes. Ultimately, the President, Medical Communications (US) secures market trust through expert scientific communication.

Ericka McKenna, the Chief Marketing Officer at Real Chemistry, directs all global brand positioning and market engagement strategies. McKenna architects high-impact campaigns that leverage AI-powered insights to elevate the commercial success of healthcare clients. By aligning marketing initiatives with the broader corporate mission, the Chief Marketing Officer ensures consistent messaging across diverse international markets. This leadership role involves managing cross-functional teams to optimize customer-centric experiences and drive brand equity. Through the integration of data-driven storytelling, McKenna enhances the visibility of the company within the competitive healthcare sector. The Chief Marketing Officer maintains rigorous standards for creative excellence while supporting the overarching business objectives of the organization. By fostering innovation in digital outreach, McKenna secures a dominant market position for the firm. Ultimately, the Chief Marketing Officer drives sustainable growth through strategic brand development and precise audience targeting.